Home
About
Overview
Sharing Data
ORCID
Help
History (18)
Treating dyslipidemia in high-risk patients: case reviews and discussion.
Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP).
The effect of terfenadine on unilateral nasal challenge with allergen.
Role of stretch in activation of smooth muscle cell lineage.
Incorporation of bevacizumab in the primary treatment of ovarian cancer.
See All 18 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Incorporation of bevacizumab in the primary treatment of ovarian cancer.
Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med. 2011 Dec 29; 365(26):2473-83.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Angiogenesis Inhibitors
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Carboplatin
Combined Modality Therapy
Disease-Free Survival
Double-Blind Method
Female
Humans
Middle Aged
Neoplasms, Glandular and Epithelial
Ovarian Neoplasms
Paclitaxel
Quality of Life
Survival Analysis
Young Adult
authors with profiles
Gini Fleming